Heart Disease Clinical Trials in San Antonio

Showing 21-40 of 262 trials

Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

NCT05966662

This investigational device exemption (IDE) study is to assess the safety and effectiveness of the Shockwave Coronary Intravascular Lithotripsy (IVL) System with the Shockwave C2+ 2Hz Coronary IVL Catheter to treat de novo, calcified, stenotic, coronary lesions prior to stenting.

Coronary Artery DiseaseMyocardial Infarction

Shockwave Medical, Inc.145 participantsStarted Dec 2023

Huntsville, Alabama, United States • La Jolla, California, United States • Washington D.C., District of Columbia, United States +15 more locations

RECRUITINGPhase 3< 1 mile

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

NCT07181109

The purpose of this study is to evaluate whether zilebesiran versus placebo reduces the risk of cardiovascular (CV) death, nonfatal myocardial infarction (MI), nonfatal stroke, or heart failure (HF) events. This is an event-driven study that will continue until the targeted number of positively adjudicated primary endpoint clinical outcome events (COEs) have been reached.

High Risk Cardiovascular DiseaseHypertensionHigh Cardiovascular Risk

Alnylam Pharmaceuticals11,000 participantsStarted Sep 2025

Huntsville, Alabama, United States • Huntsville, Alabama, United States • Sheffield, Alabama, United States +226 more locations

Shockwave C2+ 2Hz Coronary IVL Catheter in Calcified Coronary Arteries (Disrupt CAD DUO)

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Heart Disease Trials in Other Cities

Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Product Surveillance Registry

Ketones, SGLT2, HFrEF

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults

Assessment of CCM in HF With Higher Ejection Fraction

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Aventus Thrombectomy System Pulmonary Embolism Clinical Study

A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

A Study of LY3540378 in Participants With Worsening Chronic Heart Failure With Preserved Ejection Fraction (HFpEF)

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

STeroids to REduce Systemic Inflammation After Infant Heart Surgery

Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

His-Bundle Corrective Pacing in Heart Failure

Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

Other Conditions in San Antonio